Given the apparent outcome it seems you are correct and we are stuck with 'snail-mail' progress while potentially competitive therapies (that are possibly standalone) are no doubt being developed... including the use of stem cells and perhaps even 3D printing of pancreas and/or stomach.
Regarding further CR this might be of interest - Gastrointestinal average cost Phase 2 trial USD $15.8M
https://www.centerpointclinicalserv...-access-part-1-clinical-trial-cost-breakdown/
so perhaps another $7-10m will do it!
Cheers
Ann: Trading Halt, page-76
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.6¢ |
Change
-0.002(4.17%) |
Mkt cap ! $342.1M | |||
| Open | High | Low | Value | Volume |
| 4.8¢ | 4.8¢ | 4.6¢ | $400.2K | 8.603M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 1876197 | 4.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.7¢ | 613421 | 6 |
View Market Depth
| Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |